drugset / Trial / NCT07277712

A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult Volunteers

NCT07277712

Phase 1 Not yet recruiting 74 enrolled HK inno.N Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

This study aims to evaluate the pharmacokinetic (PK) following administration of IN-M00002 tablet and co-administration of tegoprazan and naproxen, and to evaluate food-effect of IN-M00002 tablet in healthy adult volunteers

Timeline

Start
2025-12-27
Primary completion
2026-05-30
Completion
2026-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject IN-M00002 Unknown
Subject Naproxen Small molecule 500 mg
Subject Tegoprazan Other / unclassified 25 mg

Indications

No indication recorded.